(Q36095001)

12 August 2017

1 reference

title

Management of poor responders in IVF. (English)

1 reference

12 August 2017

Ubaldi FM

1

1 reference

12 August 2017

Rienzi L

2

1 reference

12 August 2017

Ferrero S

3

1 reference

12 August 2017

Baroni E

4

1 reference

12 August 2017

Sapienza F

5

1 reference

12 August 2017

Cobellis L

6

1 reference

12 August 2017

Greco E

7

1 reference

12 August 2017

publication date

1 February 2005

1 reference

Reproductive BioMedicine Online

12 August 2017

published in

1 reference

12 August 2017

volume

10

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

235-246

1 reference

Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Addition of GnRH antagonist in cycles of poor responders undergoing IVF.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Effect of endometriosis on in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Outcome of in-vitro fertilization through natural cycles in poor responders.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Aneuploidy 16 in human embryos increases significantly with maternal age

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Growth hormone co-treatment for ovulation induction may enhance conception in the co-treatment and succeeding cycles, in clonidine negative but not clonidine positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Maternal ageing and aneuploid embryos--evidence from the mouse that biological and not chronological age is the important influence

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Serum inhibins A and B fall differentially as FSH rises in perimenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Diminished alpha-inhibin messenger ribonucleic acid in in vitro fertilization-embryo transfer poor responders reflects declining follicle reserve

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Relative influence of serum follicle stimulating hormone, age and other factors on ovarian response to gonadotrophin stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Antagonists in poor-responder patients

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Growth hormone increases ovarian levels of immunoreactive somatomedin C/insulin-like growth factor I in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Antimüllerian hormone serum levels: a putative marker for ovarian aging

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Pituitary response to early follicular-phase minidose gonadotropin releasing hormone agonist (GnRHa) therapy: evidence for a second flare

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Hypothalamic-pituitary ageing: progressive increase in FSH and LH concentrations throughout the reproductive life in regularly menstruating women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Effect of smoking on ovarian reserve and ovarian stimulation in in-vitro fertilization and embryo transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Young age does not protect against the adverse effects of reduced ovarian reserve--an eight year study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Inhibin A/B in HMG or recombinant FSH ovarian stimulation with cetrorelix medication.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Women with a reduced ovarian complement may have an increased risk for a child with Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Serum levels of luteinizing and follicle-stimulating hormones in normal and poor-responding patients undergoing ovarian stimulation with urofollitropin after pituitary downregulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Reproductive characteristics and the age at inception of the perimenopause in a British National Cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Chiasma frequency and maternal age in mammals.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Short term use of an LHRH agonist to treat poor responders entering an in-vitro fertilization programme

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Gonadotropins and estradiol stimulate immunoreactive insulin-like growth factor-I production by porcine granulosa cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

A double-blind cross-over controlled study to evaluate the effect of human biosynthetic growth hormone on ovarian stimulation in previous poor responders to in-vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Use of granulosa-luteal cell culture to evaluate low and high clinical responses to menotropin stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Growth hormone enhances follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

A rational approach to the management of low responders in in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Assisted conception following poor ovarian response to gonadotrophin stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Could ovarian infection impair ovarian response to gonadotrophin stimulation?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Characterization of susceptible chiasma configurations that increase the risk for maternal nondisjunction of chromosome 21

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Microdose follicular phase gonadotropin-releasing hormone agonist (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Another look at co-treatment with growth hormone and human menopausal gonadotrophins in poor ovarian responders

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Evaluation of functional ovarian reserve in 60 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

The value of increasing the dose of human menopausal gonadotropins in women who initially demonstrate a poor response.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Women with poor response to IVF have lowered circulating gonadotrophin surge-attenuating factor (GnSAF) bioactivity during spontaneous and stimulated cycles.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Role of decreased numbers of follicles on reproductive performance in young and aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Prognostic assessment of female fecundity

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Early ovarian ageing: a hypothesis. Detection and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

The Lupron screening test: tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Efficacy of natural cycle IVF: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Initial analysis of variability among basal hormone biomarkers of ovarian reserve

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Improving results with assisted reproductive technologies: individualized patient-tailored strategies for ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Ovarian Response to Follicle-Stimulating Hormone (FSH) Stimulation Depends on the FSH Receptor Genotype

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Gonadotropin stimulation following GnRH-a priming for poor responders in in vitro fertilization-embryo transfer programs.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

A test of the production line hypothesis of mammalian oogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Increase in the rate of diploidy with maternal age in unfertilized in-vitro fertilization oocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Comparison of growth hormone responses to growth hormone-releasing factor and clonidine in women with normal or poor ovarian response to gonadotropin stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase--a function of improved embryo quality

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responders

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in-vitro fertilization outcome in normo-ovulatory women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Prognostic value of day 3 estradiol on in vitro fertilization outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Cell cycle: Aetiology of age-associated aneuploidy: a mechanism based on the 'free radical theory of ageing'

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

The variability of female reproductive ageing

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Menstrual cyclicity and the pre-menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Ovarian reserve after uterine artery embolization for leiomyomata

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

Direct effect of gonadotropin-releasing hormone agonists on the rabbit ovarian follicle

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960946-7

7 January 2021

10.1016/S1472-6483(10)60946-7

Identifiers

DOI

1 reference

12 August 2017

1 reference